Prostate Cell News Volume 1.42 | Nov 5 2010

    0
    21
    Prostate Cell News 1.42, November 5, 2010.
    In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  EventsSubscribe  |  Unsubscribe

    TOP STORY

    Prostate Cancer’s Multiple Personalities Revealed 
    The research team identified secondary mutations that cause some types of prostate cancer cells to be lethal. [Press release from the Weill Cornell Medical College discussing online prepublication in Genome Research]

    Watch Procedure Now 
    Detect 7x More Prostate Epithelial Progenitor Cells
    with ProstaCult

    by STEMCELL Technologies
     
     
    CLICK HERE TO LEARN HOWSTEMCELL Technologies Inc
     



    SPECIAL FEATURE

    Interested in recruiting talented individuals? Post your career opportunities in Prostate Cell News at no cost. Contact us at info@connexoncreative.com

    Follow us on Twitter! @ProstateCell



    SCIENCE NEWS

    Scientists Develop Method to Keep Surgically-Removed Prostate Tissue Alive
    Scientists have developed a technique to keep normal and cancerous prostate tissue removed during surgery alive and functioning normally in the laboratory for up to a week. [Press release from Johns Hopkins Medicine discussing online prepublication in Cancer Research]

    High-Dose, Short-Course Radiation for Prostate Cancer Does Not Increase Side Effects or Reduce Quality of Life
    Researchers compared two groups of prostate cancer patients treated with intensity-modulated radiation therapy (IMRT). One group received conventional IMRT; the other group was treated with hypofractionated IMRT, which delivers a higher total dose of radiation in fewer sessions. [Press release from the Fox Chase Cancer Center discussing data presented at the 52nd Annual Meeting of the American Society for Radiation Oncology in San Diego]

    Watch Procedure Now 
    Use ALDEFLUOR® to Detect Prostate Precursor Cells
    by STEMCELL Technologies
     
     
    WATCH THE VIDEOSTEMCELL Technologies Inc
     



    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    LABORATORY RESEARCH

    Discovery of Non-ETS Gene Fusions in Human Prostate Cancer Using Next-Generation RNA Sequencing
    Researchers used next-generation transcriptome sequencing in order to explore the whole transcriptome of 25 human prostate cancer samples for the presence of chimeric fusion transcripts. [Genome Res]

    Human RecQL4 Helicase Plays Critical Roles in Prostate Carcinogenesis
    Here, researchers report that human RecQL4 helicase, which is implicated in the pathogenesis of a subset of cancer-prone Rothmund-Thomson syndrome, is highly elevated in metastatic prostate cancer cell lines. [Cancer Res]

    Class III Beta-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
    Here, researchers describe beta-III-tubulin immunohistochemical staining patterns of prostate tumors obtained from a broad spectrum of prostate cancer (PCa) patients, some of whom subsequently received docetaxel therapy for castration-resistant Pca. [Cancer Res]

    Dysregulation of the Mitogen Granulin in Human Cancer Through the miR-15/107 microRNA Gene Group
    In this study, researchers queried whether miR-107 and paralogs regulated granulin in human cancers. [Cancer Res]

    Knockdown of Inwardly Rectifying Potassium Channel Kir2.2 Suppresses Tumorigenesis by Inducing Reactive Oxygen Species-Mediated Cellular Senescence
    Senescence is an important determinant of treatment outcome in cancer therapy. In the present study, researchers show that knockdown of the inwardly rectifying K+ channel Kir2.2 induced growth arrest without additional cellular stress in cancer cells lacking functional p53, p16, and/or Rb. [Mol Cancer Ther]

    HOXC8 Inhibits Androgen Receptor Signaling in Human Prostate Cancer Cells by Inhibiting SRC-3 Recruitment to Direct Androgen Target Genes
    In the present study, researchers show that HOXC8 inhibits androgen receptor (AR)-mediated gene induction in LNCaP prostate cancer cells and HPr-1 AR, a non-tumorigenic prostate epithelial cell. [Mol Cancer Res]

    Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial
    Selective use of prostate-specific antigen screening for men in good health appears to reduce the risk of prostate cancer-specific mortality with minimal overtreatment. [J Clin Oncol]

    Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer
    The purpose of this study was to evaluate the effects of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. [J Clin Oncol]

    Impact of Androgen Deprivation Therapy on Physical Function and Quality of Life in Men With Non-Metastatic Prostate Cancer
    This prospective longitudinal study evaluated the effect of androgen deprivation therapy on objective and self-reported physical function. [J Clin Oncol]



    INDUSTRY NEWS

    EACH and ICER Launch Prostate Cancer Decision Aid Website
    The Employers Action Coalition on Healthcare (EACH), a group of employers, providers and health plans in Massachusetts, in conjunction with the Institute for Clinical and Economic Review (ICER), part of the Massachusetts General Hospital’s Institute for Technology Assessment, are launching a new website for patients recently diagnosed with low-risk prostate cancer. [The Institute for Clinical and Economic Review Press Release]

    Millennium and Takeda Announce Advancement of Prostate Cancer Program
    Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited announced the initiation of a Phase III clinical trial for TAK-700 in the U.S. in patients with advanced prostate cancer. [Millennium: The Takeda Oncology Company Press Release]



    POLICY NEWS

    U.S. Says Genes Should Not Be Eligible for Patents
    Reversing a longstanding policy, the federal government said on Friday that human and other genes should not be eligible for patents because they are part of nature. The new position could have a huge impact on medicine and on the biotechnology industry. [Department of Justice, United States]

    NIH Introduces Images, a Database of Images in Biomedical Literature
    More than 2.5 million images and figures from medical and life sciences journals are now available through Images, a new resource for finding images in biomedical literature. [National Institutes of Health, United States]

    NIH Recovery Act Grants to Foster Scientific Workforce Diversity
    The National Institutes of Health has awarded six grants totaling approximately $12 million over three years through a new initiative aimed at fostering a diverse scientific workforce. [National Institutes of Health, United States]

    Guidelines for Use of Stored Specimens and Access to Ancillary Data and Proposed Cost Schedule: Stored Biologic Specimens and Ancillary Data From the Collaborative Perinatal Project (CPP) (FR Doc. 2010-27183) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-27325) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27185) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27192) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-27039) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-27040) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-27049) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-26881) [National Institutes of Health, United States]

    Center for Scientific Review; Notice of Closed Meeting (FR Doc. 2010-26935) [National Institutes of Health, United States]

    National Cancer Institute; Notice of Closed Meeting (FR Doc. 2010-27410) [National Institutes of Health, United States]

    Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-27187) [National Institutes of Health, United States]



    EVENTS (Listed by Date)

    National Cancer Research Institute (NCRI) Conference 2010
    November 7-10, 2010
    Liverpool, United Kingdom

    9th Annual American Association for Cancer Research (AACR) International Conference: Frontiers in Cancer Prevention Research
    November 7-10, 2010
    Philadelphia, United States

    22nd European Organization for Research and Treatment of Cancer (EORTC)-National Cancer Institute (NCI)-American Association for Cancer Research (AACR) Symposium: Molecular Targets and Cancer Therapeutics
    November 16-19, 2010
    Berlin, Germany

    Cancer Pharmacogenetics: Personalizing Medicine
    November 22-24, 2010
    Madrid, Spain

    American Association for Cancer Research (AACR) Tumor Immunology – Basic and Clinical Advances
    November 30-December 3, 2010
    Miami, United States

    5th Annual Stem Cell Meeting on the Mesa
    December 7, 2010
    La Jolla, United States

    11th Annual Meeting of the Society of Urologic Oncology (SUO): Extraordinary Opportunities for Discovery
    December 8-9, 2010
    Bethesda, United States

    American Association for Cancer Research (AACR) Targeting PI3K/mTOR Signaling in Cancer
    February 24-27, 2011
    San Francisco, United States

    American Association for Cancer Research (AACR) Stem Cells, Development, and Cancer
    March 3-6, 2011
    Vancouver, Canada

    MENA Oncology Conference
    March 11-12, 2011
    Cairo, Egypt

    The 6th International Conference on Oncolytic Viruses as Cancer Therapeutics
    March 16-19, 2011
    Las Vegas, United States

    United Kingdom National Stem Cell Network 2011 Annual Scientific Conference
    March 30-April 1, 2011
    York, United Kingdom

    American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
    April 2-6, 2011
    Orlando, United States

    International Society for Stem Cell Research (ISSCR) 9th Annual Meeting
    June 15-18, 2011
    Toronto, Canada

    National Cancer Institute (NCI) Cancer Research Imaging Camp
    June 19-24, 2011
    St. Louis, United States

    4th Annual Advances in Biodetection & Biosensors Conference and Exhibition
    June 30-July 1, 2011
    Hamburg, Germany

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.


    JOB OPPORTUNITIES


    Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

    Lab Technologist – Tissue Culture (STEMCELL Technologies)


    Product Manager – Pluripotent Stem Cells (STEMCELL Technologies)

    Business Manager – Centre for Blood Cell Therapies (Cell Therapies)


    Recruit Top Talent

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Prostate Cell News at no cost.
    Visit here to post your career opportunities.

    Have we missed an important article or publication in Prostate Cell News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.


    Learn more about Prostate Cell News: Archives  |  Events  |  Subscribe  |  Contact Us